Find out what is in store for the pharmaceuticals sector in 2022!
The Investing News Network (INN) spoke with analysts, market watchers and insiders about which trends will impact this sector in the year ahead.
✓ Trends ✓ Forecasts ✓ Top Stocks
Table of Contents:
A Sneak Peek At What The Insiders Are Saying
“After years of plenty the drug development sector is, for the most part, in a good place ... The highs of the pandemic era could never be maintained, and many consider the current retrenchment part of the cycle."
— Evaluate Vantage, Vantage 2022 Preview Report
"It would have been a terrible business if the vaccine had failed. It would have been a write off. Obviously for Pfizer and Moderna and Johnson & Johnson, it succeeded pretty spectacularly."
— Seamus Fernandez, Guggenheim Securities
"We believe that pharma and hospitals are equally a COVID recovery play too. We don’t believe the best is behind us, we believe the best is ahead of us."
— Aditya Khemka, InCred Financial Services
Who We Are
The Investing News Network is a growing network of authoritative publications delivering independent, unbiased news and education for investors. We deliver knowledgeable, carefully curated coverage of a variety of markets including gold, cannabis, biotech and many others. This means you read nothing but the best from the entire world of investing advice, and never have to waste your valuable time doing hours, days or weeks of research yourself.
At the same time, not a single word of the content we choose for you is paid for by any company or investment advisor: We choose our content based solely on its informational and educational value to you, the investor.
So if you are looking for a way to diversify your portfolio amidst political and financial instability, this is the place to start. Right now.